2Curex
1 known investors
2cureX develops IndiTreat®, a 3D functional precision medicine test that grows patient-derived cancer cells as 3D microtumors (tumoroids) from a tumor biopsy to profile drug sensitivity and guide individualized therapy selection. The company serves oncologists and healthcare professionals, providing drug-response reports to inform cancer treatment decisions, and brings its diagnostic products through EU regulatory and reimbursement pathways.
BiotechHealthtechMedical Devices
Founders & leadership
OT
Ole ThastrupCEO, Founder and Board member
GH
Grith HagelVP Innovation, Co-Founder and Board member
KG
Kenneth Graabek JohansenCFO
JT
Jacob ThastrupCTO